期刊文献+

老年患者使用利奈唑胺致相关性血小板减少症回顾性分析 被引量:8

Retrospective Analysis of Linezolid-induced Thrombocytopenia in Elderly Patients
暂未订购
导出
摘要 目的:探讨利奈唑胺在治疗老年人医院获得性感染期间对患者血小板的影响。方法:回顾性分析2010年11月—2012年11月我院使用利奈唑胺(43例)治疗老年人医院获得性感染的临床资料,统计利奈唑胺致相关性血小板减少症发生率、降低幅度、恢复时间等指标,并分析其对治疗的影响。结果:利奈唑胺血小板减少发生率为20.9%,发生在用药后(9.33±3.28)d,血小板水平较用药前下降了(58.8±15.7)%;停用利奈唑胺后(6.44±6.39)d血小板开始上升,(8.83±2.32)d后恢复至用药前水平。结论:利奈唑胺诱导老年人血小板减少为较为常见的药品不良反应,停药后血小板可自行恢复到用药前水平。 OBJECTIVE: To investigate the effect of linezolid on platelet during treatment of hospital-acquired infections in elderly patients. METHODS: A retrospective analysis was performed on the clinical data of 43 elderly patients with hospital-acquired infections treated with linezolid in our hospital from November 2010 to November 2012 with regard to incidence rate of linezolid-induced thrombocytopenia and its reduction rate and recovery time etc as well as its effect on the treatment. RESULTS: Linezolid-induced thrombocytopenia occurred in 20. 9% of the patients at (9.33 ±3.28) days after drug administration; the platelet level decreased by 58.8% ± 15.7% as compared with before administration, but increased at (6.44 ± 6.39) days after discontinuation of linezolid until returned to the level before administration at ( 8.83 ± 2.32 ) days after discontinuation of linezolid. CONCLUSION : Linezolid-induced thrombocytopenia in the elderly is common adverse drug reactions, and the platelet can automatically return to the level before treatment after withdrawal of linezolid.
机构地区 解放军第
出处 《中国医院用药评价与分析》 2014年第1期40-43,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 利奈唑胺 医院获得性感染 血小板减少症 老年人 Linezolid Hospital acquired infection Thrombocytopenia Elderly
  • 相关文献

参考文献19

  • 1Kuter DJ,Tillotson GS. Hematologic effects of antimicrobials:focus on the oxazolidinone linezolid[J].{H}PHARMACOTHERAPY,2001,(8):1010-1013.
  • 2Gerson SL,Kaplan SL,Bruss JB. Hematologic effects of linezolid:summary of clinical experience[J].{H}Antimicrobial Agents and Chemotherapy,2002,(8):2723-2726.
  • 3Nasraway SA,Shorr AF,Kuter D J. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia:comparative analysis of linezolid and vancomycin use[J].{H}Clinical Infectious Diseases,2003,(12):1609-1616.
  • 4Walkey AJ,O'Donnell MR,Wiener RS. Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureusnosocomial pneumonia:a meta-analysis of randomized controlled trials[J].{H}CHEST,2011,(5):1148-1155.
  • 5Kalil AC,Murthy MH,Hermsen ED. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia:a systematic review and meta-analysis[J].{H}CRITICAL CARE MEDICINE,2010,(9):1802-1808.
  • 6Takahashi Y,Takesue Y,Nakajima K. Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy[J].{H}Journal of Infection and Chemotherapy,2011,(3):382-387.
  • 7Niwa T,Suzuki A,Sakakibara S. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adultJapanese patients who received intravenous linezolid therapy[J].{H}Clinical Therapeutice,2009,(10):2126-2133.
  • 8Kohno S,Yamaguchi K,Aikawa N. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcusaureus in Japan[J].{H}Journal of Antimicrobial Chemotherapy,2007,(6):1361-1369.
  • 9Lin DF,Zhang YY,Wu JF. Linezolid for the treatment of infections caused by Gram-positive pathogens in China[J].{H}International Journal of Antimicrobial Agents,2008,(3):241-249.
  • 10Ball AP,Bartlett JG,Craig WA. Future trends in antimicrobial chemotherapy:expert opinion on the 43rd ICAAC[J].{H}Journal of Chemotherapy,2004,(5):419-436.

同被引文献59

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部